Affiliation:
1. Neuroscience Area International School for Advanced Studies (SISSA/ISAS) Via Bonomea 265 34136 Trieste Italy
2. Catalan Institute of Nanoscience and Nanotechnology (ICN2) CSIC and BIST Campus UAB Bellaterra 08193 Barcelona Spain
3. Nanomedicine Lab and Faculty of Biology Medicine & Health The National Graphene Institute University of Manchester Manchester M13 9PL United Kingdom
Abstract
AbstractSmall graphene oxide (s‐GO) nanosheets reversibly downregulate central nervous system (CNS) excitatory synapses, with potential developments as future therapeutic tools to treat neuro‐disorders characterized by altered glutamatergic transmission. Excitotoxicity, namely cell death triggered by exceeding ambient glutamate fueling over‐activation of excitatory synapses, is a pathogenic mechanism shared by several neural diseases, from ischemic stroke to neurodegenerative disorders. In this work, CNS cultures were exposed to oxygen‐glucose deprivation (OGD) to mimic ischemic stroke in vitro, and it is show that the delivery of s‐GO following OGD, during the endogenous build‐up of secondary damage and excitotoxicity, improved neuronal survival. In a different paradigm, excitotoxicity cell damage was reproduced through exogenous glutamate application, and s‐GO co‐treatment protected neuronal integrity, potentially by directly downregulating the synaptic over‐activation brought about by exogenous glutamate. This proof‐of‐concept study suggests that s‐GO may find novel applications in therapeutic developments for treating excitotoxicity‐driven neural cell death.
Funder
HORIZON EUROPE European Innovation Council
Subject
General Chemistry,Catalysis,Organic Chemistry
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献